HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice.

Abstract
A disintegrin and metalloprotease 33 (ADAM33) is a transmembrane protease and integrin ligand that has been identified as an asthma susceptibility gene product. To determine whether ADAM33 plays important roles in mammalian development and the modulation of allergic airway dysfunction, we generated ADAM33-null mice by gene targeting. ADAM33-null mice were born at expected Mendelian ratios, and both male and females developed normally and were fertile. No anatomical or histological abnormalities were detected in any tissues. In an animal model of allergic asthma, ADAM33-null mice showed normal allergen-induced airway hyperreactivity, immunoglobulin E production, mucus metaplasia, and airway inflammation. Our results demonstrate that ADAM33 is not essential for growth or reproduction in the mouse and does not modulate baseline or allergen-induced airway responsiveness.
AuthorsChun Chen, Xiaozhu Huang, Dean Sheppard
JournalMolecular and cellular biology (Mol Cell Biol) Vol. 26 Issue 18 Pg. 6950-6 (Sep 2006) ISSN: 0270-7306 [Print] United States
PMID16943435 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Immunoglobulin E
  • ADAM Proteins
  • Adam33 protein, mouse
Topics
  • ADAM Proteins (deficiency, metabolism)
  • Allergens (immunology)
  • Animals
  • Asthma (chemically induced, physiopathology)
  • Breeding
  • Bronchial Hyperreactivity (physiopathology)
  • Female
  • Gene Targeting
  • Growth and Development
  • Heterozygote
  • Immunoglobulin E (biosynthesis)
  • Inflammation (immunology)
  • Lung (pathology)
  • Male
  • Metaplasia
  • Mice
  • Mice, Knockout
  • Mucus
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: